NCT02975700 2026-01-13
A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma
Daiichi Sankyo
Phase NA Completed
Daiichi Sankyo
Miltenyi Biomedicine GmbH
Cytoastra
DermaSensor, Inc.
Cancer Intelligence Care Systems, Inc.
Clinical Laserthermia Systems AB
Skin Analytics Limited
Elucid Labs Inc.
Oncovision Inc